Short answer
CONMED Corp (CNMD) filed an 8-K current report with the SEC on June 17, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). John E. Gallagher becomes Executive Vice President, CFO, principal financial officer and principal accounting officer on July 15, 2026.
CONMED Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- John E. Gallagher becomes Executive Vice President, CFO, principal financial officer and principal accounting officer on July 15, 2026
- Gallagher brings CFO experience at Certara and Cue Health, plus medical technology finance leadership at Becton Dickinson
- Annual base salary $650,000 with target cash bonus of 85% of base salary
- Initial equity grants total $3.8 million, including options, restricted stock units, performance stock units and make-whole awards
- Patrick Beyer and Kimberly Lockwood relinquish interim finance roles while retaining other CONMED positions
Item 7.01 · Regulation FD Disclosure
- Standard Regulation FD disclaimer limiting Exchange Act Section 18 liability for the disclosure
- Information excluded from incorporation into registration statements unless expressly referenced
Item EX-99.1 · Exhibit EX-99.1
- John E. Gallagher appointed CFO effective July 15, 2026, replacing Todd Garner
- Garner remains as advisor through November 2, 2026, supporting leadership transition continuity
- Gallagher brings nearly three decades of finance experience across Certara, Cue Health, BD, GE, and Ford
- Leadership change adds medical-technology and public-company finance expertise relevant to CONMED’s strategic execution
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CONMED Corp 8-K filings
Get the next CNMD 8-K as it lands
Follow CNMD for push alerts, or ask the research agent what this filing means.